ClinicalTrials.govpublic full text
Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN
blastic plasmacytoid dendritic cell neoplasm (bpdcn), blastic plasmacytoid dendritic cell neoplasm, natural killer (nk) cell blastic lymphoma, hematologic malignancies, cluster of differentiation (cd) cd4+cd56+ hematodermic tumor, acute leukemia and myeloid neoplasms, chimeric antigen receptor t-cell (car-t) therapy, allogeneic, cluster of differentiation 4 (cd4), cluster of differentiation 56 (cd56), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.